Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia
出版年份 2012 全文链接
标题
Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia
作者
关键词
-
出版物
PEDIATRIC BLOOD & CANCER
Volume 60, Issue 6, Pages 957-963
出版商
Wiley
发表日期
2012-12-19
DOI
10.1002/pbc.24420
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dexamethasone (DEX) versus prednisone (PRED) during induction for children with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children’s Oncology Group Study AALL0232.
- (2017) N. J. Winick et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of high-dose methotrexate (HD-MTX) with Capizzi methotrexate plus asparaginase (C-MTX/ASNase) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children’s Oncology Group Study AALL0232.
- (2017) E. C. Larsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome in adolescent and young adult (AYA) patients compared with younger patients treated for high-risk B-precursor acute lymphoblastic leukemia (HR-ALL): A report from the Children’s Oncology Group study AALL0232.
- (2017) Eric Larsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia
- (2012) J. J. Yang et al. BLOOD
- Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study
- (2012) I.-M. Chen et al. BLOOD
- Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
- (2012) Y. H. Messinger et al. BLOOD
- Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia
- (2012) S. K. Tasian et al. BLOOD
- Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL
- (2012) M. Morak et al. BLOOD
- Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia
- (2012) S. L. Maude et al. BLOOD
- Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
- (2012) Kathryn G. Roberts et al. CANCER CELL
- IGH@Translocations,CRLF2Deregulation, and Microdeletions in Adolescents and Adults With Acute Lymphoblastic Leukemia
- (2012) Anthony V. Moorman et al. JOURNAL OF CLINICAL ONCOLOGY
- Pilot Study of Nelarabine in Combination With Intensive Chemotherapy in High-Risk T-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
- (2012) Kimberly P. Dunsmore et al. JOURNAL OF CLINICAL ONCOLOGY
- ARID5BGenetic Polymorphisms Contribute to Racial Disparities in the Incidence and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia
- (2012) Heng Xu et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
- (2012) Stephen P. Hunger et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial
- (2012) Leonard A Mattano et al. LANCET ONCOLOGY
- Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia
- (2012) C Palmi et al. LEUKEMIA
- Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE)
- (2012) L Orsi et al. LEUKEMIA
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
- (2012) Jinghui Zhang et al. NATURE
- Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
- (2012) Martin Schrappe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
- (2011) Y. Matloub et al. BLOOD
- Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
- (2011) L. E. Hogan et al. BLOOD
- Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study
- (2011) H. Kang et al. BLOOD
- Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
- (2011) J. Zhang et al. BLOOD
- Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
- (2011) N. Hijiya et al. BLOOD
- Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles
- (2011) M G Loudin et al. LEUKEMIA
- Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia
- (2011) E Ellinghaus et al. LEUKEMIA
- Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia
- (2011) Jun J Yang et al. NATURE GENETICS
- Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults
- (2011) Eric S. Schafer et al. Nature Reviews Clinical Oncology
- Outcome after first relapse in children with acute lymphoblastic leukemia: A report based on the Dutch Childhood Oncology Group (DCOG) relapse all 98 protocol
- (2011) H. van den Berg et al. PEDIATRIC BLOOD & CANCER
- Improving outcomes for high-risk ALL: Translating new discoveries into clinical care
- (2011) Stephen P. Hunger et al. PEDIATRIC BLOOD & CANCER
- Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol
- (2010) G. Cario et al. BLOOD
- Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
- (2010) R. C. Harvey et al. BLOOD
- Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
- (2010) R. C. Harvey et al. BLOOD
- Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial
- (2010) H. M. Ensor et al. BLOOD
- Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005
- (2010) Maurizio Aricò et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
- (2010) Malcolm A. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90
- (2010) Gesche Tallen et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial
- (2010) Catriona Parker et al. LANCET
- Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium
- (2010) Yoav Messinger et al. PEDIATRIC BLOOD & CANCER
- Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia
- (2009) H. Kang et al. BLOOD
- Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
- (2009) L. Hertzberg et al. BLOOD
- Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
- (2009) L. J. Russell et al. BLOOD
- Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia
- (2009) Franco Locatelli et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic Leukemia
- (2009) Jun J. Yang JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Young Adults With Acute Lymphoblastic Leukemia Have an Excellent Outcome With Chemotherapy Alone and Benefit From Intensive Postinduction Treatment: A Report From the Children's Oncology Group
- (2009) James B. Nachman et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2009) Kirk R. Schultz et al. JOURNAL OF CLINICAL ONCOLOGY
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
- (2009) Monique L Den Boer et al. LANCET ONCOLOGY
- A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
- (2009) N Hijiya et al. LEUKEMIA
- Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984–2001: a report from the children's oncology group
- (2009) W L Salzer et al. LEUKEMIA
- Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004
- (2009) W A Kamps et al. LEUKEMIA
- Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)
- (2009) L B Silverman et al. LEUKEMIA
- Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia
- (2009) C H Pui et al. LEUKEMIA
- Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
- (2009) A Möricke et al. LEUKEMIA
- Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia
- (2009) V Conter et al. LEUKEMIA
- Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: A Children's Oncology Group Report
- (2009) P S Gaynon et al. LEUKEMIA
- Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia
- (2009) Charles G Mullighan et al. NATURE GENETICS
- Germline genomic variants associated with childhood acute lymphoblastic leukemia
- (2009) Lisa R Treviño et al. NATURE GENETICS
- Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia
- (2009) Charles G. Mullighan et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK mutations in high-risk childhood acute lymphoblastic leukemia
- (2009) C. G. Mullighan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group
- (2008) D. French et al. BLOOD
- Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia
- (2008) J. J. Yang et al. BLOOD
- What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
- (2008) W. Stock et al. BLOOD
- Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
- (2008) M. J. Borowitz et al. BLOOD
- Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study
- (2008) Elizabeth A. Raetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Reinduction Platform for Children With First Marrow Relapse of Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2008) Elizabeth A. Raetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression Signatures Predictive of Early Response and Outcome in High-Risk Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2008) Deepa Bhojwani et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
- (2008) Dani Bercovich et al. LANCET
- Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
- (2008) K Nguyen et al. LEUKEMIA
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
- (2008) C. G. Mullighan et al. SCIENCE
- Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program
- (2007) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search